Industry Growth Insights published a new data on “Artificial Intelligence (AI) in Drug Discovery Market”. The research report is titled “Artificial Intelligence (AI) in Drug Discovery Market research by Types (Software, Services, Artificial Intelligence (AI) in Drug Discover), By Applications (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes), By Players/Companies IBM, Microsoft, Google, NVIDIA Corporation, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, BenevolentAI, Exscientia, Cyclica, BIOAGE, Numerate, NuMedii, Envisagenics, twoXAR, OWKIN, Inc., XtalPi, Verge Genomics, BERG LLC, Artificial Intelligence (AI) in Drug Discover”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Intelligence (AI) in Drug Discovery Market Research Report
By Type
Software, Services, Artificial Intelligence (AI) in Drug Discover
By Application
Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes
By Companies
IBM, Microsoft, Google, NVIDIA Corporation, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, BenevolentAI, Exscientia, Cyclica, BIOAGE, Numerate, NuMedii, Envisagenics, twoXAR, OWKIN, Inc., XtalPi, Verge Genomics, BERG LLC, Artificial Intelligence (AI) in Drug Discover
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
 in Drug Discovery Industry Outlook.svg)
Global Artificial Intelligence (AI) in Drug Discovery Market Report Segments:
The global Artificial Intelligence (AI) in Drug Discovery market is segmented on the basis of:
Types
Software, Services, Artificial Intelligence (AI) in Drug Discover
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- IBM
- Microsoft
- Google
- NVIDIA Corporation
- Atomwise, Inc.
- Deep Genomics
- Cloud Pharmaceuticals
- Insilico Medicine
- BenevolentAI
- Exscientia
- Cyclica
- BIOAGE
- Numerate
- NuMedii
- Envisagenics
- twoXAR
- OWKIN, Inc.
- XtalPi
- Verge Genomics
- BERG LLC
- Artificial Intelligence (AI) in Drug Discover
 in Drug Discovery Market Overview.svg)
Highlights of The Artificial Intelligence (AI) in Drug Discovery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Software
- Services
- Artificial Intelligence (AI) in Drug Discover
- By Application:
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Research Centers and Academic & Government Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Intelligence (AI) in Drug Discovery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 in Drug Discovery Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial intelligence (AI) is a computer science technique that allows machines to learn from data and make decisions on their own. It can be used in drug discovery to help identify potential drug targets, predict how drugs will work in humans, and develop new ways to test drugs. AI can also help researchers design better clinical trials.
Some of the major players in the artificial intelligence (ai) in drug discovery market are IBM, Microsoft, Google, NVIDIA Corporation, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, BenevolentAI, Exscientia, Cyclica, BIOAGE, Numerate, NuMedii, Envisagenics, twoXAR, OWKIN, Inc., XtalPi, Verge Genomics, BERG LLC, Artificial Intelligence (AI) in Drug Discover.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Intelligence (AI) in Drug Discovery Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Artificial Intelligence (AI) in Drug Discovery Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Artificial Intelligence (AI) in Drug Discovery Market - Supply Chain
4.5. Global Artificial Intelligence (AI) in Drug Discovery Market Forecast
4.5.1. Artificial Intelligence (AI) in Drug Discovery Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Artificial Intelligence (AI) in Drug Discovery Market Size (000 Units) and Y-o-Y Growth
4.5.3. Artificial Intelligence (AI) in Drug Discovery Market Absolute $ Opportunity
5. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Type
5.3.1. Software
5.3.2. Services
5.3.3. Artificial Intelligence (AI) in Drug Discover
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical & Biotechnology Companies
6.3.2. Contract Research Organizations
6.3.3. Research Centers and Academic & Government Institutes
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Artificial Intelligence (AI) in Drug Discovery Demand Share Forecast, 2019-2026
9. North America Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical & Biotechnology Companies
9.4.2. Contract Research Organizations
9.4.3. Research Centers and Academic & Government Institutes
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Type
9.7.1. Software
9.7.2. Services
9.7.3. Artificial Intelligence (AI) in Drug Discover
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Artificial Intelligence (AI) in Drug Discovery Demand Share Forecast, 2019-2026
10. Latin America Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical & Biotechnology Companies
10.4.2. Contract Research Organizations
10.4.3. Research Centers and Academic & Government Institutes
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Type
10.7.1. Software
10.7.2. Services
10.7.3. Artificial Intelligence (AI) in Drug Discover
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Artificial Intelligence (AI) in Drug Discovery Demand Share Forecast, 2019-2026
11. Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical & Biotechnology Companies
11.4.2. Contract Research Organizations
11.4.3. Research Centers and Academic & Government Institutes
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Type
11.7.1. Software
11.7.2. Services
11.7.3. Artificial Intelligence (AI) in Drug Discover
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Artificial Intelligence (AI) in Drug Discovery Demand Share, 2019-2026
12. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical & Biotechnology Companies
12.4.2. Contract Research Organizations
12.4.3. Research Centers and Academic & Government Institutes
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Type
12.7.1. Software
12.7.2. Services
12.7.3. Artificial Intelligence (AI) in Drug Discover
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Artificial Intelligence (AI) in Drug Discovery Demand Share, 2019-2026
13. Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical & Biotechnology Companies
13.4.2. Contract Research Organizations
13.4.3. Research Centers and Academic & Government Institutes
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Market Size and Volume Forecast by Type
13.7.1. Software
13.7.2. Services
13.7.3. Artificial Intelligence (AI) in Drug Discover
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Artificial Intelligence (AI) in Drug Discovery Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Artificial Intelligence (AI) in Drug Discovery Market: Market Share Analysis
14.2. Artificial Intelligence (AI) in Drug Discovery Distributors and Customers
14.3. Artificial Intelligence (AI) in Drug Discovery Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. IBM
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Microsoft
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Google
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. NVIDIA Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Atomwise, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Deep Genomics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cloud Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Insilico Medicine
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BenevolentAI
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Exscientia
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cyclica
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BIOAGE
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Numerate
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. NuMedii
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Envisagenics
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. twoXAR
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. OWKIN, Inc.
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. XtalPi
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Verge Genomics
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. BERG LLC
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
